SIBN
SI-BONE, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$18.09
+0.28%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$18.08
From 52W high−15.47%
Volume829871.00
Market cap$810.77M
P/E (TTM)—
P/S (TTM)3.8x
Div yield—
Key dataSep 18, 2026
Open
$18.08
From 52W high
−15.47%
Volume
829871.00
Market cap
$810.77M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−134.5x
P/E (TTM)
—
RSI (14)
40.5
MomentumView details →
1D Return
+0.28%
YTD Return
−8.77%
SummaryUpdated Jun 1, 2026
SI-BONE, Inc. (NASDAQ:SIBN) is a medical device company founded in 2008 and headquartered in Santa Clara, California. The company went public in October 2018 and specializes in developing and commercializing implantable devices that address musculoskeletal disorders of the sacropelvic anatomy. What began as a single-product company focused on sacroiliac joint dysfunction has evolved into a multi-modality medical device platform targeting various conditions affecting the sacropelvic region, including adult spinal deformity, pelvic trauma, and related orthopedic conditions.
Similar companies
Latest newsMore news →
SI-BONE, Inc. amended its lease with BIXBY SPE FINANCE 11, LLC, extending the term by one month to October 31, 2026 at a base rent of $43,696.00 per month.9d agoSI-BONE shares fell 10.29% in after-hours trading to $16.55, following a 3.89% gain during the regular session to $18.45, on August 3, 2026.48d agoSI-BONE, Inc. reported financial results for the second quarter of 2026, with approximately 15% worldwide revenue growth and about a 178% increase in adjusted EBITDA, and raised its 2026 guidance.48d ago